A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

Recent advances towards mass spectrometry-based clinical lipidomics




TekijätSalihovic Samira, Lamichane Santosh, Hyötyläinen Tuulia, Orešič Matej

KustantajaElsevier Ltd

Julkaisuvuosi2023

JournalCurrent Opinion in Chemical Biology

Tietokannassa oleva lehden nimiCurrent Opinion in Chemical Biology

Artikkelin numero102370

Vuosikerta76

eISSN1879-0402

DOIhttps://doi.org/10.1016/j.cbpa.2023.102370

Verkko-osoitehttps://www.sciencedirect.com/science/article/pii/S1367593123001084?via%3Dihub

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/180479017


Tiivistelmä

The objective of this review is to provide a comprehensive summary of the latest methodological advancements and emerging patterns in utilizing lipidomics in clinical research.In this review, we assess the recent advancements in lipidomics methodologies that exhibit high levels of selectivity and sensitivity, capable of generating numerous molecular lipid species from limited quantities of biological matrices.

The reviewed studies demonstrate that molecular lipid signatures offer new opportunities for precision medicine by providing sensitive diagnostic tools for disease prediction and monitoring. Moreover, the latest innovations in microsampling techniques have the potential to make a substantial contribution to clinical lipidomics. The review also shows that more work is needed to harmonize results across diverse lipidomics platforms and avoid significant errors in analysis and reporting. The increased implementation of internal standards and standard reference materials in analytical workflows will aid in this direction.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-27-03 at 22:04